股东及董事减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 股东及董事持股的基本情况 本次减持计划实施前，北京映翰通网络技术股份有限公司（以下简称"公司"） 股东常州德丰杰清洁技术创业投资中心（有限合伙）（以下简称"德丰杰"）持有 公司股份 1,629,071 股，占公司总股本的比例为 2.21%。公司董事、副总经理、 核心技术人员韩传俊先生持有公司股份 3,172,273 股，占公司总股本的比例为 4.30%。 上述股份均为公司 IPO 前及资本公积转增股本取得股份，并已于 2021 年 2 月 18 日解除限售后上市流通。 证券代码：688080 证券简称：映翰通 公告编号：2025-057 北京映翰通网络技术股份有限公司 二、减持计划的实施结果 减持计划的实施结果情况 2025 年 7 月 10 日，公司披露了《股东减持股份计划公告》（公告编号： 2025-037），股东德丰杰因自身资金需求拟通过证券交易所集中竞价交易方式减 持其所持有公司股份数量合计不超过 1,629,0 ...

每经AI快讯，10月15日，映翰通公告，常州德丰杰清洁技术创业投资中心(有限合伙)及董事韩传俊先生 分别在2025年7月10日披露了减持股份计划。德丰杰拟减持不超过162.91万股(占总股本2.21%)，韩传俊 拟减持不超过5万股(占总股本0.07%)。截至2025年10月15日，德丰杰实际减持142.71万股，韩传俊实际 减持2.80万股，两者的减持计划均未完全完成。其中，韩传俊先生决定提前终止减持计划，剩余2.20万 股不再减持。 ...

Market Performance - On the first trading day after the holiday, A-shares saw a strong performance with the Shanghai Composite Index rising by 1.24%, surpassing the 3900-point mark for the first time in over 10 years [1] - The Shenzhen Component Index increased by 1.75%, while the ChiNext Index rose by 1.77% [1] - The total trading volume in the Shanghai and Shenzhen markets reached 17.269 billion yuan, an increase of 3.571 billion yuan compared to the previous day, with 3200 stocks rising across the market [1] Sector Highlights - The international gold price broke the 4000 USD mark, leading to significant gains in the gold and non-ferrous metal sectors, with stocks like Chifeng Jilong Gold Mining and Sichuan Gold hitting the daily limit [1] - The controlled nuclear fusion concept saw strong performance, with stocks such as Guoguang Electric and Hanhua Welding Technology also hitting the daily limit, following key breakthroughs in China's nuclear fusion device construction [1] - The semiconductor sector experienced a surge, with companies like Zhaoxin Semiconductor and Huahong Semiconductor reaching historical highs [1] - Rare earth permanent magnet stocks collectively rose, with Antai Technology hitting the daily limit and other companies like Jinkeli Permanent Magnet and Zhongkuang Resources increasing by over 8% due to export controls on related rare earth items [1] Underperforming Sectors - The film and cinema sector faced declines, with Huace Film and Television dropping over 12% and other companies like Hengdian Film and China Film hitting the daily limit down, as the 2025 National Day box office fell short of last year's figures [1] - The liquor sector also saw declines, with Gujing Distillery and Huangtai Liquor both dropping over 3% [1] - The real estate sector experienced widespread declines, with Shen Shen Fang A hitting the daily limit down and Zhangjiang Hi-Tech dropping over 9% [1]

Group 1 - On September 25, Ruishun Technology executed a block trade of 118,000 shares, with a transaction value of 4.13 million yuan, accounting for 2% of the total trading volume for the day [1] - The transaction price was 35 yuan, representing a discount of 15.34% compared to the market closing price of 41.34 yuan [1] Group 2 - The trading date for the securities was September 25, 2025, with the stock code 688080 for Ruishun Technology [2] - The transaction involved a volume of 210,000 shares at a price of 35 yuan, with a total transaction amount of 2.1 million yuan [2]

Core Viewpoint - The company is closely monitoring the development dynamics of the embodied intelligent robot industry, including humanoid robots, recognizing significant future potential and market space due to advancements in artificial intelligence, sensors, and motion control technologies. However, humanoid robots are still in a phase of rapid technological evolution and application exploration, with a considerable distance remaining before large-scale industrialization [1]. Group 1: Industry Insights - The humanoid robot sector is characterized by rapid technological advancements and ongoing exploration of applications, indicating a nascent stage in its development [1]. - The industry has substantial growth potential and market opportunities driven by technological progress in related fields [1]. Group 2: Company Positioning - The company has established a technological relevance to the robot industry through its existing business in foundational technology areas such as industrial internet, communication connectivity, and intelligent control [1]. - The company is committed to maintaining a forward-looking approach in research and monitoring technological advancements and industry application opportunities, aligning with its business development strategy and core advantages [1].

Core Viewpoint - The company is closely monitoring the development dynamics of the embodied intelligent robot industry, including humanoid robots, recognizing significant future potential and market space due to advancements in artificial intelligence, sensors, and motion control technologies. However, humanoid robots are still in a phase of rapid technological evolution and application exploration, with a considerable distance remaining before large-scale industrialization [1]. Group 1: Industry Insights - The humanoid robot sector is characterized by rapid technological advancements and ongoing exploration of applications, indicating a nascent stage in its development [1]. - The industry has substantial growth potential and market opportunities driven by technological progress in related fields [1]. Group 2: Company Positioning - The company has established a technological relevance to the robot industry through its existing business in foundational technology areas such as industrial internet, communication connectivity, and intelligent control [1]. - The company is committed to maintaining a forward-looking approach in research and monitoring technological advancements and industry application opportunities, aligning with its business development strategy and core advantages [1].

Group 1 - The focus is on the information technology self-controllable sector, with the Xinchuang ETF fund (562030) experiencing a mid-session increase of 2.68% and currently up by 1.96% [1] - Among the constituent stocks, Neusoft Group leads with over 6% increase, followed by Chengdu Huami and Kingsoft Office with over 4% gains, and other stocks like Deepin Technology, 360 Security, and CloudWalk Technology also showing upward trends [1] Group 2 - Multiple cybersecurity listed companies are actively investing in AI technology research and development, with Deepin Technology applying large model technology to network security products, creating AI firewalls and other security products [3] - Ant Group has recently launched innovative products and solutions that integrate network security and AI technology, including the gPass framework for smart glasses, which has partnered with brands like Rokid and Xiaomi [3] - Market analysts indicate that the application of AI technology will lead to explosive growth across various industries, but security issues are limiting data circulation [3] Group 3 - Dongguan Securities notes that the Xinchuang industry is steadily advancing according to a "2+8+N" rhythm, transitioning from policy-driven to a dual drive of policy and market [4] - The market scale is expected to grow significantly, with projected growth rates of 17.84% and 26.82% for 2025 and 2026 respectively, and the market is anticipated to exceed 2.6 trillion yuan by 2026 [4] Group 4 - The Xinchuang ETF fund (562030) and its linked funds are designed to passively track the CSI Xinchuang Index, which covers key segments of the Xinchuang industry chain, including hardware, software, application software, and information security [6] - The investment logic for the Xinchuang industry includes international geopolitical disturbances, increased local debt efforts, technological breakthroughs by domestic manufacturers, and the critical timing of procurement standards [6]

Group 1 - The A-share market saw a significant decline in brain-computer interface concept stocks, with several companies experiencing drops of over 5% [1] - Notable companies that fell over 5% include Dineike, Xiangyu Medical, Meihao Medical, Chengdu Huamei, and Tom Cat [1] - Other companies such as Yanshan Technology, Zhongke Information, Aipeng Medical, Nanjing Panda, Weisi Medical, Innovation Medical, Robot, Mailande, Beiqingsong, Botuo Biological, and Rongtai Health dropped over 4% [1]

Group 1 - The company announced the issuance of stock for equity incentive purposes [2] - The method of stock subscription is offline, with a total of 250,320 shares to be listed [2] - The total number of shares available for circulation is also 250,320, with a circulation date set for September 25, 2025 [2]

证券代码：688080 证券简称：映翰通 公告编号：2025-056 北京映翰通网络技术股份有限公司 本次股票上市类型为股权激励股份；股票认购方式为网下，上市股数为 250,320股。 本次股票上市流通总数为250,320股。 本次股票上市流通日期为2025 年 9 月 25 日。 根据中国证券监督管理委员会、上海证券交易所、中国证券登记结算有限责 任公司上海分公司有关业务规则的规定，北京映翰通网络技术股份有限公司（以 下简称"公司"）于 2025 年 9 月 18 日收到中国证券登记结算有限责任公司上海分 公司出具的《证券变更登记证明》，公司已完成 2023 年限制性股票激励计划（以 下简称"本激励计划"）第二个归属期归属股份的登记工作。现将有关情况公告如 下： 一、本次限制性股票归属的决策程序及相关信息披露 1、2023 年 3 月 15 日，公司召开第四届董事会第三次会议，审议通过《北京 映翰通网络技术股份有限公司 2023 年限制性股票激励计划（草案）及摘要》《北 京映翰通网络技术股份有限公司 2023 年限制性股票激励计划实施考核管理办法》 《关于提请股东大会授权董事会办理公司 2023 年限制性股 ...